Movement Disorders · 2010 · 34 citations · 32 references
Life SciencesNeurologyNeuroscienceMolecular NeuroscienceNeurodegenerationNeurogeneticsNeurodegenerative DiseasesNeurodegenerative DisordersOlfactory NeuroscienceOlfactory ProcessingParkinson DiseaseParkinsonian DisordersDisease DurationLrrk2 MutationsNeurodegenerative Disease-associated Smell LossNeurodegenerative Disease-related Olfactory DysfunctionNeurodegenerative Olfactory LossOdor DetectionOlfactory PathologyParkinson's Disease Genetics
LRRK2 mutations can cause familial and sporadic Parkinson's disease (PD) with Lewy-body pathology at post-mortem. Studies of olfaction in LRRK2 are sparse and incongruent. We applied a previously validated translation of the 16 item smell identification test from Sniffin' Sticks (SS-16) to 14 parkinsonian carriers of heterozygous G2019S LRRK2 mutation and compared with 106 PD patients and 118 healthy controls. The mean SS-16 score in LRRK2 was higher than in PD (p < 0.001, 95% CI for β = -4.7 to -1.7) and lower than in controls (p = 0.007, 95% CI for β = +0.6 to +3.6). In the LRRK2 group, subjects with low scores had significantly more dyskinesia. They also had younger age of onset, longer disease duration, and reported less frequently a family history of PD, but none of these other differences reached significance. Odor identification is diminished in LRRK2 parkinsonism but not to the same extent as in idiopathic PD.
32
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Alexander Zimprich, Saskia Biskup, Petra Leitner et al. · Neuron · 2004 · 3.1K citations · Full text
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Jeffrey H. Kordower, Yaping Chu, Robert A. Hauser et al. · Nature Medicine · 2008 · 1.7K citations